Patents by Inventor Michael C. Little

Michael C. Little has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5620869
    Abstract: It has been found that certain glycoproteins, particularly mucins, are inhibitors of nucleic acid amplification reactions and that inhibition of the amplification reaction is associated with partial degradation of the carbohydrate chain. Partial degradation of the carbohydrate of a non-inhibitory glycoprotein renders it inhibitory, and partial degradation of the carbohydrate of a slightly inhibitory glycoprotein makes it more inhibitory. Sample processing prior to amplification may contribute to partial degradation of the carbohydrate chains of the glycoproteins which are present and increase their inhhibitory effect. In contrast, complete removal of the carbohydrate significantly reduces or completely eliminates the inhibitory effect. Methods for reducing or eliminating glycoprotein-associated inhibition of nucleic acid amplification reactions are also disclosed.
    Type: Grant
    Filed: September 28, 1995
    Date of Patent: April 15, 1997
    Assignee: Becton, Dickinson and Company
    Inventors: Daniel L. Woodard, Adriann H. Walters, Michael C. Little
  • Patent number: 5612182
    Abstract: Mycobacteriophage DS6A has been characterized and found to specifically infect all species of the TB complex, without any detectable infection of mycobacteria species other than those of the TB complex. DNA sequence analysis revealed several potential open reading frames, including one encoding a protein analogous to gp37 of mycobacteriophage L5 and a second encoding a protein with significant homology to the S. coelicolor DNA polymerase .beta. subunit. Based on the DNA sequence analysis, cloning sites can be identified for insertion of reporter genes, making DS6A useful as a reporter phage for specific detection and identification of species of the TB complex.
    Type: Grant
    Filed: March 10, 1995
    Date of Patent: March 18, 1997
    Assignee: Becton, Dickinson and Company
    Inventors: Robert E. Pearson, Julie A. Dickson, Paul T. Hamilton, Michael C. Little, Wayne F. Beyer, Jr.
  • Patent number: 5582969
    Abstract: Mycobacteriophage DS6A has been characterized and found to specifically infect all species of the TB complex, without any detectable infection of mycobacteria species other than those of the TB complex. DNA sequence analysis revealed several potential open reading frames, including one encoding a protein analogous to gp37 of mycobacteriophage L5 and a second encoding a protein with significant homology to the S. coelicolor DNA polymerase .beta. subunit. Based on the DNA sequence analysis, cloning sites can be identified for insertion of reporter genes, making DS6A useful as a reporter phage for specific detection and identification of species of the TB complex.
    Type: Grant
    Filed: July 27, 1995
    Date of Patent: December 10, 1996
    Assignee: Becton, Dickinson and Company
    Inventors: Robert E. Pearson, Julie A. Dickson, Paul T. Hamilton, Michael C. Little, Wayne F. Beyer, Jr.
  • Patent number: 5554503
    Abstract: Methods for processing samples which may contain mycobacteria which are compatible with both conventional culturing techniques and nucleic acid analysis. It has been found that the harsh chemical treatment previously thought necessary to obtain efficient lysis can be eliminated without loss of lysis efficiency, thereby eliminating reagents which may inhibit subsequent nucleic acid-based reactions. Heat alone is sufficient to lyse mycobacteria, even in buffers which do not contain detergents, chelators, enzymes, etc. Residual reagents introduced by conventional sample processing methods for culture can be successfully removed from the processed pellet without significant loss of microorganisms by at least two washings with saline, water, or buffers compatible with nucleic acid analysis and appropriate centrifugation.
    Type: Grant
    Filed: August 4, 1994
    Date of Patent: September 10, 1996
    Assignee: Becton, Dickinson and Company
    Inventors: James A. Down, Adriann H. Walters, Margaret S. Dey, Deborah R. Howard, Michael C. Little, William E. Keating
  • Patent number: 5494796
    Abstract: Genus- and species-specific oligonucleotide probes derived from the M. paratuberculosis 70 kD heat shock protein gene sequence. The probes are useful for detecting Mycobacteria and for identifying specific species of Mycobacteria.
    Type: Grant
    Filed: July 14, 1994
    Date of Patent: February 27, 1996
    Assignee: Becton Dickinson and Company
    Inventors: Patricia A. Spears, Michael C. Little, Daryl D. Shank
  • Patent number: 5476768
    Abstract: Mycobacteriophage DS6A has been characterized and found to specifically infect all species of the TB complex, without any detectable infection of mycobacteria species other than those of the TB complex. DNA sequence analysis revealed several potential open reading frames, including one encoding a protein analogous to gp37 of mycobacteriophage L5 and a second encoding a protein with significant homology to the S. coelicolor DNA polymerase .beta. subunit. Based on the DNA sequence analysis, cloning sites can be identified for insertion of reporter genes, making DS6A useful as a reporter phage for specific detection and identification of species of the TB complex.
    Type: Grant
    Filed: March 10, 1995
    Date of Patent: December 19, 1995
    Assignee: Becton, Dickinson and Company
    Inventors: Robert E. Pearson, Julie A. Dickson, Paul T. Hamilton, Michael C. Little, Wayne F. Beyer, Jr.
  • Patent number: 5457027
    Abstract: Methods employing internal oligonucleotide standards in isothermal nucleic acid amplification reactions to determine the efficacy of the amplification reaction and to quantify pre-amplification target levels.
    Type: Grant
    Filed: May 5, 1993
    Date of Patent: October 10, 1995
    Assignee: Becton, Dickinson and Company
    Inventors: James G. Nadeau, Michael C. Little
  • Patent number: 5422252
    Abstract: Methods for multiplex amplification of target nucleic acid sequences using a single pair of primers. Defined sequences are appended to the ends of multiple target sequences as part of the amplification reaction so that no steps in addition to amplification are required. The target sequences with the appended defined sequences need not be isolated prior to amplification. In one embodiment for coamplification of two target sequences, a sequence corresponding to a terminal segment of the first target sequence is appended to one end of the second target sequence and a sequence corresponding to a terminal segment of the second target sequence is appended to one end of the first target sequence. Amplification of the two targets then requires only a single pair of primers. Alternatively, a single defined sequence may be appended to the 5' and 3' ends of any number of selected targets. All such modified target sequences may then be amplified using a single pair of primers which hybridize to the defined end-sequences.
    Type: Grant
    Filed: June 4, 1993
    Date of Patent: June 6, 1995
    Assignee: Becton, Dickinson and Company
    Inventors: George T. Walker, James G. Nadeau, Michael C. Little
  • Patent number: 5270184
    Abstract: The invention is a method for generating nucleic acid sequences ends which comprises;(a) hybridizing a primer to a nucleic acid sequence,(b) hybridizing a primer to the nucleic acid sequence in (a) located 5' to the primer in (a), and(c) polymerizing both primers so that the primer in (a) is displaced from the nucleic acid sequence.The invention provides a method for generating target nucleic acid sequences for subsequent amplification. The method is applicable to both DNA and RNA.
    Type: Grant
    Filed: November 19, 1991
    Date of Patent: December 14, 1993
    Assignee: Becton, Dickinson and Company
    Inventors: George T. Walker, Michael C. Little, James G. Nadeau
  • Patent number: 5075430
    Abstract: This invention is directed to a process for the purification of plasmid and other DNA, both single-stranded and double-stranded, by immobilizing the DNA onto diatomaceous earth in the presence of a chaotropic agent and eluting the DNA with water or low salt buffer. The resulting purified DNA is biologically active. Also included in the invention is a process for the immobilization of DNA onto diatomaceous earth in the presence of a chaotropic agent.
    Type: Grant
    Filed: December 18, 1990
    Date of Patent: December 24, 1991
    Assignee: Bio-Rad Laboratories, Inc.
    Inventor: Michael C. Little